[Immunosuppressive treatment of skin diseases. II. Clinical use of immunosuppressive drugs].
D000963:Antimetabolites / Q000627:therapeutic use; D004485:Eczema / Q000188:drug therapy; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008545:Melanoma / Q000188:drug therapy; D008727:Methotrexate / Q000627:therapeutic use; D010392:Pemphigus / Q000188:drug therapy; D010916:Pityriasis Rubra Pilaris / Q000188:drug therapy; D011230:Precancerous Conditions / Q000188:drug therapy; D011565:Psoriasis / Q000188:drug therapy; D012867:Skin / Q000276:immunology; D012871:Skin Diseases / Q000188:drug therapy* / Q000276:immunology; D013262:Stevens-Johnson Syndrome / Q000188:drug therapy
D000963:Antimetabolites; D007166:Immunosuppressive Agents; D006918:Hydroxyurea; D008727:Methotrexate
Leczenie immunosupresyjne choròb skòry. II. astosowanie kliniczne srodkòw immunosupresyjnych